Johnson & Johnson’s Ethicon subsidiary was ordered to pay plaintiff Ella Ebaugh $57 million dollars for injuries she suffered from their transvaginal mesh implants. The verdict, rendered in Philadelphia Common Pleas Court, was the largest verdict in the Philadelphia  mass tort litigation. … Read More


A Pennsylvania state court jury awarded $2.16 million in damages to a woman with an Ethicon ProLift +M Pelvic Floor Repair System which eroded inside her body and cannot be removed. This is the fourth consecutive win for plaintiffs in the Philadelphia Court of Common Pleas, and the fourth multi-million dollar award against Johnson & Johnson and its subsidiary Ethicon. It is the first time punitive damages were not awarded.… Read More


A jury has returned a verdict of $20,000,000 for a New Jersey woman who has been in constant pain since receiving a vaginal mesh implant made by Johnson & Johnson’s Ethicon unit. The jury awarded $2.5 million in compensatory damages for pain, suffering, and economic loss, and $17.5 million in punitive damages to punish J&J and Ethicon for failing to warn about the risks of mesh implants.… Read More


A Philadelphia jury has awarded $13.5 million to Sharon Carolino who claimed permanent damages from an Ethicon TVT midurethral sling mesh implant. This was the second verdict against Johnson & Johnson’s Ethicon unit in a pelvic mesh case. In December a jury awarded $12.5 million against J&J for injuries caused by another mesh product, the Ethicon ProLift pelvic organ prolapse repair kit.… Read More


A new lawsuit accuses transvaginal mesh manufacturer Boston Scientific of smuggling counterfeit pelvic mesh from China. Boston Scientific is charged with intentionally defrauding and endangering women by secretly importing defective polypropylene resin that wasn’t approved by the FDA.… Read More


The FDA has issued a final order reclassifying transvaginal mesh used to repair Pelvic Organ Prolapse (POP) from class II (moderate-risk) to class III (high-risk). The FDA will also require manufacturers of every surgical mesh used to treat POP to conduct a PreMarket Approval application demonstrating the safety and effectiveness of their mesh product for treating POP. Manufacturers have 30 months — two and one half years — to show that their products are safe and effective for POP. These new FDA orders do not apply to mesh sold for Stress Urinary Incontinence (SUI) or abdominal repair.… Read More


An Indiana woman was awarded $12.5 million dollars against Johnson & Johnson’s Ethicon unit in damages for the injuries she suffered from their ProLift transvaginal mesh implant. The Court of Common Pleas jury awarded $5.5 million dollars in compensatory damages and added $7 million dollars in punitive damages to punish Johnson & Johnson for recklessly marketing the device.… Read More


Posted by Marilyn McGoldrick on Mar 6, 2015 9:58:22 AM   Johnson & Johnson’s Ethicon unit has been ordered to pay $5.7 million dollars to a California woman who was damaged by a TVT-Abbrevo pelvic mesh sling device. Thousands of defective transvaginal mesh products have been implanted in women suffering from the medical conditions Pelvic… Read More


Posted by Marilyn McGoldrick on Feb 24, 2015 12:12:07 PM   Mesh manufacturer C.R. Bard is reportedly in talks to settle the thousands of pelvic mesh lawsuits pending against it in federal and state courts across the country. At the urging of federal judge Joseph R. Goodwin, C.R. Bard’s attorneys and plaintiffs’ lead counsel have been… Read More


Posted by Marilyn McGoldrick on Jan 14, 2015 12:29:03 PM   The federal judge overseeing all transvaginal mesh litigation has denied C.R. Bard’s motion to delay bellwether trials, also known as test trials, scheduled for next month. C.R. Bard, a defendant in more than 12,000 cases brought by women who received defective Avaulta pelvic mesh… Read More